comparemela.com

Latest Breaking News On - Aktiia - Page 2 : comparemela.com

Aktiia: Experts up the pressure on global professional bodies to revise Blood Pressure monitoring guidelines

New publication reveals clear benefits of cuffless BP monitors for the first time, as experts call for guidelines to enable their use NEUCHATEL, Switzerland, May 17, 2022 /PRNewswire/

Neuchatel
Neuchâl
Switzerland
United-kingdom
Jay-shah
Kostenloser-wertpapierhandel
Frontiers-in-medical-technology
Blood-pressure
Medical-technology
Chief-medical-officer
Aktiia
Experts

World's first automated 24/7 blood pressure monitor comes to the USA

/PRNewswire/ Aktiia, the global leader in continuous blood pressure monitoring, today announced that it is bringing its 24/7 Blood Pressure Monitor to the.

United-states
Germany
United-kingdom
Italy
Austria
Ireland
Switzerland
France
Americans
Swiss
Naomi-fisher
Jayb-shah

Aktiia launches into healthcare market with $17.5M investment for its world-first 24-7 Blood Pressure Monitoring System

NEUCHATEL, Switzerland, Nov. 3, 2021 /PRNewswire/ Hypertension health-tech firm Aktiia today announced a $17.5M Series A round of funding that will be used to accelerate its expansion in

Germany
United-kingdom
Italy
Neuchatel
Neuchâl
Switzerland
Austria
Ireland
France
Swiss
Richard-cardow
Kostenloser-wertpapierhandel

Aktiia Receives CE Mark Approval for Breakthrough 24-7 Blood Pressure Monitoring System

Aktiia Receives CE Mark Approval for Breakthrough 24-7 Blood Pressure Monitoring System First-ever Optical Blood Pressure Monitoring System for 24-7 Use Now Available in the United Kingdom Aktiia s clinically validated Optical Blood Pressure Monitoring technology estimates blood pressure accurately, automatically, and painlessly, by analyzing signals from the wearer s wrist NEUCHATEL, Switzerland, Jan. 26, 2021 /PRNewswire/ Aktiia today announced the first 24-7, automated blood pressure monitoring system that easily and comfortably gathers data during the day and while sleeping. This groundbreaking medical innovation will now provide people and their physicians comprehensive insights into blood pressure patterns that will better inform the diagnosis and management of hypertension. Now available for sale in the United Kingdom, Aktiia has received its CE Mark as a Class IIa medical device - signifying that the device has been assessed to meet high safety, health and environm

Neuchatel
Neuchal
Switzerland
United-kingdom
London
City-of
Swiss
Kostenloser-wertpapierhandel
Neil-poulter
Mattia-bertschi
Josep-sola
Mike-kisch

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.